GlassScriptPrepare for your visit
Usman Bhutta
Nephrology (Internal Medicine) · Oklahoma City, OK · NPI 1588896997
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,185.90
in general payments reported to CMS, 2019-2025 · $594 in 2025
The $594 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Who reported paying
General payments only, top 6 by amount.
- Amgen INC. $406.32
- Outset Medical INC $282.74
- Bayer Healthcare Pharmaceuticals INC. $184.55
- Alexion Pharmaceuticals, INC. $169.09
- Otsuka Pharmaceutical Development & Commercialization, INC. $168.50
- Vantive US Healthcare LLC $149.11
Drugs and devices associated with these payments
Krystexxa Renal - Pd Tavneos Purified Cortrophin Gel Jardiance Ibsrela Jynarque Kerendia Ozempic Monoferric Vafseo Wegovy
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Usman Bhutta listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/298551/usman-bhutta